The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group.
In contrast to previous decades, the 1990s have witnessed an increase of new agents with significant activity in breast cancer, including chemotherapy, hormone therapy, and, more recently, biologic modifiers. All information appears to confirm that such a trend will persist and even accelerate in the coming decades. Unless clear strategies of development for new drugs are strictly followed, it will become difficult to adequately assess the many new agents with potentially important activity against breast cancer, and patient access may become a limiting key factor. The academic, global virtual concept is calling for the definition of a new relationship between the pharmaceutical industry and clinical researchers. The main aspect is related to the creation of partnerships with an academically controlled global strategy of development for promising new agents, in which the quality and independence of processes (adjuvant setting, for example) are critical. The means are based on the globalization of patient access (worldwide network) and the virtuality of the approach (modern means of communication as well as access to subgroups of patients). The Breast Cancer International Research Group is the first academic global virtual cooperative group in breast cancer and is making contributions in the development of new drugs, such as taxanes, new antiestrogens, and new cytokines.
Northern Alberta Breast Cancer Program, Cross Cancer Institute, Edmonton, Canada.
J M
JM
Nabholtz
M A
MA
Lindsay
J
J
Hugh
J
J
Mackey
M
M
Smylie
H J
HJ
Au
K
K
Tonkin
M
M
Allen
D000046:Academic Medical Centers; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004345:Drug Industry; D006801:Humans; D007400:Interprofessional Relations; D008495:Medical Oncology / Q000639:trends; D012106:Research
D000970:Antineoplastic Agents